MEDP - Medpace Holdings Stock Price, News & Analysis

$36.42 0.21 (0.58 %)
(As of 11/24/2017 04:00 PM ET)
Previous Close$36.21
Today's Range$36.14 - $36.91
52-Week Range$21.76 - $39.64
Volume65,300 shs
Average Volume171,673 shs
Market Capitalization$1.37 billion
P/E Ratio24.78
Dividend YieldN/A
Beta-0.34

About Medpace Holdings (NASDAQ:MEDP)

Medpace Holdings logoMedpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.


Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MEDP
CUSIPN/A

Debt

Debt-to-Equity Ratio0.36%
Current Ratio0.68%
Quick Ratio0.68%

Price-To-Earnings

Trailing P/E Ratio24.78
Forward P/E Ratio24.28
P/E Growth1.87

Sales & Book Value

Annual Sales$421.58 million
Price / Sales3.25
Cash Flow$2.77 per share
Price / Cash13.13
Book Value$14.63 per share
Price / Book2.49

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPS$0.68
Net Income$13.42 million
Net Margins6.44%
Return on Equity10.00%
Return on Assets6.19%

Miscellaneous

Employees2,500
Outstanding Shares37,610,000

Frequently Asked Questions for Medpace Holdings (NASDAQ:MEDP)

What is Medpace Holdings' stock symbol?

Medpace Holdings trades on the NASDAQ under the ticker symbol "MEDP."

How were Medpace Holdings' earnings last quarter?

Medpace Holdings, Inc. (NASDAQ:MEDP) released its quarterly earnings results on Monday, October, 30th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The business had revenue of $98.68 million for the quarter, compared to analyst estimates of $96.84 million. Medpace Holdings had a net margin of 6.44% and a return on equity of 10.00%. Medpace Holdings's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period last year, the firm earned $0.40 earnings per share. View Medpace Holdings' Earnings History.

Where is Medpace Holdings' stock going? Where will Medpace Holdings' stock price be in 2017?

7 brokers have issued 1-year price targets for Medpace Holdings' shares. Their forecasts range from $34.00 to $38.00. On average, they anticipate Medpace Holdings' stock price to reach $35.75 in the next year. View Analyst Ratings for Medpace Holdings.

What are Wall Street analysts saying about Medpace Holdings stock?

Here are some recent quotes from research analysts about Medpace Holdings stock:

  • 1. According to Zacks Investment Research, "Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. " (11/14/2017)
  • 2. Jefferies Group LLC analysts commented, "Medpace boasts eye-popping margin, strong cash flow, and an enticing correlation to fast growing biotech customers. With its group-high valuation, MEDP's risk, in our view, is that investors have looked through management's "conservative" guidance to upsides, akin to prior CRO post-IPO performances. 1.05x BtB, lower 2017 revenue guidance, and in-line EPS will likely pressure the stock a little on Tuesday." (2/28/2017)

Who are some of Medpace Holdings' key competitors?

Who are Medpace Holdings' key executives?

Medpace Holdings' management team includes the folowing people:

  • August J. Troendle M.D., Chairman of the Board, President, Chief Executive Officer (Age 60)
  • Jesse J. Geiger CPA, Chief Financial Officer, Chief Operating Officer - Laboratory Operations (Age 42)
  • Susan E. Burwig, Executive Vice President - Operations (Age 54)
  • Penelope J. Bucknell, Vice President - Human Resources (Age 58)
  • Stephen P. Ewald J.D., General Counsel, Corporate Secretary (Age 47)
  • Anastasya Molodykh, Director
  • John R. Richardson, Director
  • Bruce Brown, Independent Director (Age 59)
  • Brian T. Carley, Independent Director (Age 63)
  • Robert O. Kraft, Independent Director (Age 47)

When did Medpace Holdings IPO?

(MEDP) raised $150 million in an initial public offering on Thursday, August 11th 2016. The company issued 7,000,000 shares at $20.00-$23.00 per share. Jefferies, Credit Suisse, UBS Investment Bank and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers.

Who owns Medpace Holdings stock?

Medpace Holdings' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Ameriprise Financial Inc. (1.11%), Granite Investment Partners LLC (0.79%), Fisher Asset Management LLC (0.33%), OxFORD Asset Management LLP (0.26%), Prudential Financial Inc. (0.19%) and Russell Investments Group Ltd. (0.10%). Company insiders that own Medpace Holdings stock include August J Troendle, Medpace Limited Partnership and Susan E Burwig. View Institutional Ownership Trends for Medpace Holdings.

Who sold Medpace Holdings stock? Who is selling Medpace Holdings stock?

Medpace Holdings' stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Prudential Financial Inc., Osborn Williams & Donohoe LLC and California State Teachers Retirement System. View Insider Buying and Selling for Medpace Holdings.

Who bought Medpace Holdings stock? Who is buying Medpace Holdings stock?

Medpace Holdings' stock was acquired by a variety of institutional investors in the last quarter, including Ameriprise Financial Inc., Fisher Asset Management LLC, Russell Investments Group Ltd., GSA Capital Partners LLP, OxFORD Asset Management LLP, Granite Investment Partners LLC, Citadel Advisors LLC and American Century Companies Inc.. Company insiders that have bought Medpace Holdings stock in the last two years include August J Troendle and Susan E Burwig. View Insider Buying and Selling for Medpace Holdings.

How do I buy Medpace Holdings stock?

Shares of Medpace Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medpace Holdings' stock price today?

One share of Medpace Holdings stock can currently be purchased for approximately $36.42.

How big of a company is Medpace Holdings?

Medpace Holdings has a market capitalization of $1.37 billion and generates $421.58 million in revenue each year. The company earns $13.42 million in net income (profit) each year or $0.68 on an earnings per share basis. Medpace Holdings employs 2,500 workers across the globe.

How can I contact Medpace Holdings?

Medpace Holdings' mailing address is 5375 MEDPACE WAY, CINCINNATI OH, 45227. The company can be reached via phone at 513-579-9911 or via email at [email protected]


MarketBeat Community Rating for Medpace Holdings (MEDP)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  89 (Vote Underperform)
Total Votes:  167
MarketBeat's community ratings are surveys of what our community members think about Medpace Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Medpace Holdings (NASDAQ:MEDP)

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.202.302.442.50
Ratings Breakdown: 0 Sell Ratings
8 Hold Ratings
2 Buy Ratings
0 Strong Buy Ratings
0 Sell Ratings
7 Hold Ratings
3 Buy Ratings
0 Strong Buy Ratings
0 Sell Ratings
5 Hold Ratings
4 Buy Ratings
0 Strong Buy Ratings
0 Sell Ratings
4 Hold Ratings
4 Buy Ratings
0 Strong Buy Ratings
Consensus Price Target: $36.33$34.33$34.00$32.90
Price Target Upside: 5.65% upside2.52% upside14.21% upside24.91% upside

Consensus Price Target History for Medpace Holdings (NASDAQ:MEDP)

Price Target History for Medpace Holdings (NASDAQ:MEDP)

Analysts' Ratings History for Medpace Holdings (NASDAQ:MEDP)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/1/2017Jefferies Group LLCBoost Price TargetHold$34.00 -> $38.00N/AView Rating Details
11/1/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
10/31/2017Robert W. BairdBoost Price TargetNeutral$32.00 -> $35.00N/AView Rating Details
10/17/2017KeyCorpReiterated RatingHoldN/AView Rating Details
9/29/2017Raymond James Financial, Inc.Initiated CoverageMkt Perform -> Market PerformLowView Rating Details
6/6/2017Credit Suisse GroupReiterated RatingOutperform$35.00 -> $36.00LowView Rating Details
5/3/2017Wells Fargo & CompanyDowngradeOutperform -> Market PerformHighView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for Medpace Holdings (NASDAQ:MEDP)

Earnings by Quarter for Medpace Holdings (NASDAQ:MEDP)

Earnings History by Quarter for Medpace Holdings (NASDAQ MEDP)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017Q3 2017$0.36$0.40$96.84 million$98.68 millionViewN/AView Earnings Details
7/31/2017Q2 2017$0.30$0.38$92.71 million$94.60 millionViewN/AView Earnings Details
5/1/2017Q1 2017$0.37$0.34$93.61 million$93.80 millionViewListenView Earnings Details
2/27/2017Q416$0.34$0.35$94.40 million$95.38 millionViewListenView Earnings Details
11/3/2016Q316$0.34$0.40$91.42 million$94.80 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Medpace Holdings (NASDAQ:MEDP)
2017 EPS Consensus Estimate: $1.41
2018 EPS Consensus Estimate: $1.71
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.38$0.38$0.38
Q2 20173$0.29$0.30$0.30
Q3 20173$0.35$0.36$0.36
Q4 20173$0.37$0.38$0.38
Q1 20183$0.39$0.41$0.40
Q2 20183$0.42$0.43$0.42
Q3 20183$0.43$0.44$0.44
Q4 20183$0.44$0.46$0.45
Q1 20191$0.45$0.45$0.45
Q2 20191$0.46$0.46$0.46
Q3 20191$0.50$0.50$0.50
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Medpace Holdings (NASDAQ:MEDP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Medpace Holdings (NASDAQ MEDP)

Insider Ownership Percentage: 25.80%
Institutional Ownership Percentage: 17.94%
Insider Trades by Quarter for Medpace Holdings (NASDAQ:MEDP)
Institutional Ownership by Quarter for Medpace Holdings (NASDAQ:MEDP)

Insider Trades by Quarter for Medpace Holdings (NASDAQ MEDP)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/22/2017Medpace Limited PartnershipMajor ShareholderSell2,000,000$30.27$60,540,000.00View SEC Filing  
8/18/2016August J TroendleCEOBuy10,000$27.98$279,800.00View SEC Filing  
8/17/2016Susan E BurwigInsiderBuy19,211$29.21$561,153.31View SEC Filing  
8/16/2016August J TroendleCEOBuy869,565$23.00$19,999,995.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Medpace Holdings (NASDAQ MEDP)

Source:
DateHeadline
$97.43 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter$97.43 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter
www.americanbankingnews.com - November 23 at 10:22 AM
Zacks: Brokerages Expect Medpace Holdings, Inc. (MEDP) to Post $0.38 EPSZacks: Brokerages Expect Medpace Holdings, Inc. (MEDP) to Post $0.38 EPS
www.americanbankingnews.com - November 21 at 1:26 PM
ETFs with exposure to Medpace Holdings, Inc. : November 17, 2017ETFs with exposure to Medpace Holdings, Inc. : November 17, 2017
finance.yahoo.com - November 17 at 3:57 PM
Medpace Holdings, Inc. (MEDP) Receives Consensus Recommendation of "Hold" from BrokeragesMedpace Holdings, Inc. (MEDP) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 6 at 3:46 AM
Medpace Holdings, Inc. :MEDP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017Medpace Holdings, Inc. :MEDP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 2, 2017
finance.yahoo.com - November 3 at 5:18 PM
ETFs with exposure to Medpace Holdings, Inc. : November 3, 2017ETFs with exposure to Medpace Holdings, Inc. : November 3, 2017
finance.yahoo.com - November 3 at 5:18 PM
 Analysts Expect Medpace Holdings, Inc. (MEDP) Will Announce Quarterly Sales of $97.43 Million Analysts Expect Medpace Holdings, Inc. (MEDP) Will Announce Quarterly Sales of $97.43 Million
www.americanbankingnews.com - November 3 at 10:51 AM
Jefferies Group Analysts Raise Earnings Estimates for Medpace Holdings Inc (MEDP)Jefferies Group Analysts Raise Earnings Estimates for Medpace Holdings Inc (MEDP)
www.americanbankingnews.com - November 2 at 8:53 AM
FY2017 EPS Estimates for Medpace Holdings Inc (MEDP) Lifted by William BlairFY2017 EPS Estimates for Medpace Holdings Inc (MEDP) Lifted by William Blair
www.americanbankingnews.com - November 2 at 8:53 AM
Equities Analysts Set Expectations for Medpace Holdings Incs FY2017 Earnings (MEDP)Equities Analysts Set Expectations for Medpace Holdings Inc's FY2017 Earnings (MEDP)
www.americanbankingnews.com - November 2 at 8:52 AM
Analysts Issue Forecasts for Medpace Holdings, Inc.s Q1 2018 Earnings (MEDP)Analysts Issue Forecasts for Medpace Holdings, Inc.'s Q1 2018 Earnings (MEDP)
www.americanbankingnews.com - November 1 at 2:04 PM
William Blair Research Analysts Lift Earnings Estimates for Medpace Holdings, Inc. (MEDP)William Blair Research Analysts Lift Earnings Estimates for Medpace Holdings, Inc. (MEDP)
www.americanbankingnews.com - November 1 at 9:18 AM
Edited Transcript of MEDP earnings conference call or presentation 31-Oct-17 1:00pm GMTEdited Transcript of MEDP earnings conference call or presentation 31-Oct-17 1:00pm GMT
finance.yahoo.com - November 1 at 6:10 AM
Medpace Holdings, Inc. (MEDP) Price Target Raised to $35.00 at Robert W. BairdMedpace Holdings, Inc. (MEDP) Price Target Raised to $35.00 at Robert W. Baird
www.americanbankingnews.com - October 31 at 10:48 AM
Medpace Holdings, Inc. (MEDP) Issues Quarterly  Earnings Results, Beats Estimates By $0.04 EPSMedpace Holdings, Inc. (MEDP) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS
www.americanbankingnews.com - October 31 at 8:56 AM
Medpace Holdings, Inc. Reports Third Quarter 2017 ResultsMedpace Holdings, Inc. Reports Third Quarter 2017 Results
finance.yahoo.com - October 31 at 5:16 AM
Medpace beats Street 3Q forecastsMedpace beats Street 3Q forecasts
finance.yahoo.com - October 31 at 5:16 AM
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare ConferenceMedpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
finance.yahoo.com - October 31 at 5:16 AM
Medpace Holdings, Inc. (MEDP) Set to Announce Earnings on WednesdayMedpace Holdings, Inc. (MEDP) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - October 25 at 5:24 AM
$95.30 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter$95.30 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter
www.americanbankingnews.com - October 15 at 1:32 PM
 Brokerages Expect Medpace Holdings, Inc. (MEDP) Will Announce Earnings of $0.36 Per Share Brokerages Expect Medpace Holdings, Inc. (MEDP) Will Announce Earnings of $0.36 Per Share
www.americanbankingnews.com - October 13 at 6:20 AM
Medpace Holdings, Inc. (MEDP) Receives Consensus Rating of "Buy" from AnalystsMedpace Holdings, Inc. (MEDP) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - October 12 at 2:44 AM
FY2017 EPS Estimates for Medpace Holdings, Inc. (MEDP) Lifted by AnalystFY2017 EPS Estimates for Medpace Holdings, Inc. (MEDP) Lifted by Analyst
www.americanbankingnews.com - October 10 at 8:06 AM
How Vantiv helped Cincinnati investment pro rise in stock contestHow Vantiv helped Cincinnati investment pro rise in stock contest
www.bizjournals.com - October 9 at 9:05 PM
Medpace Holdings (MEDP) "Hold" Rating Reiterated at Robert W. BairdMedpace Holdings' (MEDP) "Hold" Rating Reiterated at Robert W. Baird
www.americanbankingnews.com - October 9 at 3:16 PM
Head to Head Review: Medpace Holdings (MEDP) versus Its PeersHead to Head Review: Medpace Holdings (MEDP) versus Its Peers
www.americanbankingnews.com - October 9 at 12:38 PM
Medpace Holdings, Inc. to Report Third Quarter 2017 Financial Results on October 30, 2017Medpace Holdings, Inc. to Report Third Quarter 2017 Financial Results on October 30, 2017
finance.yahoo.com - October 6 at 10:21 AM
Does Medpace Holdings Inc’s (MEDP) PE Ratio Signal A Selling Opportunity?Does Medpace Holdings Inc’s (MEDP) PE Ratio Signal A Selling Opportunity?
finance.yahoo.com - October 2 at 5:20 PM
Medpace Holdings, Inc. (MEDP) Now Covered by Analysts at Raymond James Financial, Inc.Medpace Holdings, Inc. (MEDP) Now Covered by Analysts at Raymond James Financial, Inc.
www.americanbankingnews.com - September 29 at 10:02 AM
PAREXELs Acquisition by Pamplona Approved by Shareholders - NasdaqPAREXEL's Acquisition by Pamplona Approved by Shareholders - Nasdaq
www.nasdaq.com - September 27 at 3:48 PM
 Brokerages Expect Medpace Holdings, Inc. (MEDP) Will Post Earnings of $0.36 Per Share Brokerages Expect Medpace Holdings, Inc. (MEDP) Will Post Earnings of $0.36 Per Share
www.americanbankingnews.com - September 24 at 2:28 PM
Medpace Holdings, Inc. (MEDP) Given Consensus Rating of "Buy" by AnalystsMedpace Holdings, Inc. (MEDP) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - September 17 at 2:50 AM
Medpace Holdings, Inc. (MEDP) Expected to Post Quarterly Sales of $95.10 MillionMedpace Holdings, Inc. (MEDP) Expected to Post Quarterly Sales of $95.10 Million
www.americanbankingnews.com - September 7 at 7:38 AM
BRIEF-Medpace Holdings files for mixed shelf of up to $75 million ‍BRIEF-Medpace Holdings files for mixed shelf of up to $75 million ‍
www.reuters.com - September 2 at 7:36 PM
Medpace Holdings, Inc. to Present at Wells Fargo Healthcare ConferenceMedpace Holdings, Inc. to Present at Wells Fargo Healthcare Conference
finance.yahoo.com - August 24 at 9:08 AM
Medpace Holdings, Inc. (MEDP) Given Average Recommendation of "Hold" by BrokeragesMedpace Holdings, Inc. (MEDP) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - August 23 at 3:32 AM
Insider Selling: Medpace Holdings, Inc. (MEDP) Major Shareholder Sells 2,000,000 Shares of StockInsider Selling: Medpace Holdings, Inc. (MEDP) Major Shareholder Sells 2,000,000 Shares of Stock
www.americanbankingnews.com - August 22 at 7:16 PM
Medpace Holdings (MEDP) & Voyager Therapeutics (VYGR) Head to Head AnalysisMedpace Holdings (MEDP) & Voyager Therapeutics (VYGR) Head to Head Analysis
www.americanbankingnews.com - August 21 at 10:26 AM
BRIEF-Medpace Holdings announces stock repurchase agreement with CinvenBRIEF-Medpace Holdings announces stock repurchase agreement with Cinven
www.reuters.com - August 18 at 6:42 AM
ETFs with exposure to Medpace Holdings, Inc. : August 16, 2017ETFs with exposure to Medpace Holdings, Inc. : August 16, 2017
finance.yahoo.com - August 17 at 2:32 AM
Medpace Holdings, Inc. Announces Stock Repurchase Agreement with CinvenMedpace Holdings, Inc. Announces Stock Repurchase Agreement with Cinven
finance.yahoo.com - August 17 at 2:32 AM
Medpace Holdings, Inc. :MEDP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 4, 2017Medpace Holdings, Inc. :MEDP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 4, 2017
finance.yahoo.com - August 5 at 2:45 AM
FY2019 EPS Estimates for Medpace Holdings, Inc. Raised by William Blair (NASDAQ:MEDP)FY2019 EPS Estimates for Medpace Holdings, Inc. Raised by William Blair (NASDAQ:MEDP)
www.americanbankingnews.com - August 4 at 7:40 PM
FY2017 EPS Estimates for Medpace Holdings, Inc. Raised by William Blair (MEDP)FY2017 EPS Estimates for Medpace Holdings, Inc. Raised by William Blair (MEDP)
www.americanbankingnews.com - August 3 at 9:50 AM
Medpace Holdings, Inc. (MEDP) Receives Hold Rating from Jefferies Group LLCMedpace Holdings, Inc. (MEDP) Receives Hold Rating from Jefferies Group LLC
www.americanbankingnews.com - August 2 at 4:38 PM
Jefferies Group Analysts Increase Earnings Estimates for Medpace Holdings, Inc. (MEDP)Jefferies Group Analysts Increase Earnings Estimates for Medpace Holdings, Inc. (MEDP)
www.americanbankingnews.com - August 2 at 7:02 AM
Edited Transcript of MEDP earnings conference call or presentation 1-Aug-17 1:00pm GMTEdited Transcript of MEDP earnings conference call or presentation 1-Aug-17 1:00pm GMT
finance.yahoo.com - August 2 at 5:09 AM
Head-To-Head Contrast: Zynerba Pharmaceuticals (ZYNE) & Medpace Holdings (MEDP)Head-To-Head Contrast: Zynerba Pharmaceuticals (ZYNE) & Medpace Holdings (MEDP)
www.americanbankingnews.com - August 1 at 8:30 PM
Medpace Holdings, Inc. (NASDAQ:MEDP) Announces  Earnings ResultsMedpace Holdings, Inc. (NASDAQ:MEDP) Announces Earnings Results
www.americanbankingnews.com - July 31 at 9:10 PM
Medpace Holdings, Inc. Reports Second Quarter 2017 ResultsMedpace Holdings, Inc. Reports Second Quarter 2017 Results
finance.yahoo.com - July 31 at 8:09 PM

Social Media

Financials

Chart

Medpace Holdings (NASDAQ MEDP) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.